Clinical Trials Directory

Trials / Sponsors / Tango Therapeutics, Inc.

Tango Therapeutics, Inc.

Industry · 6 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
RecruitingStudy to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC
Phase 1 / Phase 22025-05-31
RecruitingSafety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With
Non Small Cell Lung Cancer, Glioma Glioblastoma Multiforme, Glioma, Malignant
Phase 1 / Phase 22025-03-24
TerminatedStudy to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors
Breast Cancer, Ovarian Cancer, Pancreas Cancer
Phase 1 / Phase 22023-12-08
RecruitingStudy of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors
Non Small Cell Lung Cancer, Solid Tumors, Adult, Lung Cancer
Phase 1 / Phase 22023-06-12
RecruitingSafety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Locally Advanced Solid Tumor
Phase 1 / Phase 22023-05-26
TerminatedSafety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors
Locally Advanced Solid Tumor
Phase 1 / Phase 22022-03-23